Xalatan

Xalatan ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a prostaglandin analogue that works by increasing the outflow of aqueous fluid from the eyes.
It is also known by the brand name of Xalatan manufactured by Pfizer.

Xalatan - Pharmacology:

Xalatan is a prostaglandin F2a analogue. Specifically, Xalatan is a prostanoid selective FP receptor agonist that is believed to reduce the intraocular pressure (IOP) by increasing the outflow of aqueous humor. Studies in animals and man suggest that the main mechanism of action is increased uveoscleral outflow. Elevated IOP represents a major risk factor for glaucomatous field loss. The higher the level of IOP, the greater the likelihood of optic nerve damage and visual field loss.

Xalatan mini report

Xalatan NDA
NDA - A product marketed under an approved New Drug Application
Xalatan OPHTHALMIC
OPHTHALMIC
Xalatan HUMAN PRESCRIPTION DRUG
HUMAN PRESCRIPTION DRUG
Start - Stop data
START DATA:
1995-Mar-20
Start - Stop data
STOP DATA
not occurred

Xalatan Interactions

In vitro studies have shown that precipitation occurs when eye drops containing thimerosal are mixed with latanoprost. If such drugs are used they should be administered with an interval of at least 5 minutes between applications.

Xalatan Contraindications

Known hypersensitivity to latanoprost, benzalkonium chloride or any other ingredients in this product.

Xalatan tags categories:

Generic name, Overdose, Half Life Xalatan, Food Interactions, Chemical, etc..

Xalatan see also FDA report

Eye drop